LOCK-UP AGREEMENTLock-Up Agreement • March 28th, 2022 • Eagle Pharmaceuticals, Inc. • Pharmaceutical preparations • Delaware
This lock-up agreement, dated March ____, 2022 (this “Agreement”), by and between the undersigned holder (the “Holder”) and Eagle Pharmaceuticals, Inc., a Delaware corporation (the “Buyer”), is being executed and delivered in connection with the co-operation agreement, dated as of March ____, 2022 (the “Co-operation Agreement”), by and among the Buyer and Acacia Pharma Group PLC, a public company limited by shares, incorporated in England and Wales whose registered office is at The Officers’ Mess Royston Road, Duxford, Cambridge, England, CB22 4QH with company number 09759376 (the “Company”), pursuant to which the Buyer intends to acquire the entire issued and to be issued share capital of the Company (the “Acquisition”) which is proposed to be implemented by way of a scheme of arrangement under Part 26 of the UK Companies Act 2006 (the “Scheme”), with the Company continuing as a wholly-owned subsidiary of the Buyer, pursuant to the terms and subject to the conditions provided for in t
Dated 27 March 2022 Eagle Pharmaceuticals, Inc. and Acacia Pharma Group PLC CO- OPERATION AGREEMENT relating to THE PROPOSED SCHEME OF ARRANGEMENT OF ACACIA PHARMA GROUP PLCCo-Operation Agreement • March 28th, 2022 • Eagle Pharmaceuticals, Inc. • Pharmaceutical preparations • England and Wales
